Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008;52(2):157-66.
doi: 10.1159/000129651. Epub 2008 Apr 29.

Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants

Affiliations
Randomized Controlled Trial

Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants

Renate L Bergmann et al. Ann Nutr Metab. 2008.

Abstract

Background/aims: The supply of docosahexaenoic acid (DHA, 22:6omega-3), important for fetal/infant neurodevelopment, depends on the maternal fatty acid (FA) status, which may be marginal in central Europe. Therefore, we investigated the effect of a daily vitamin/mineral supplement with and without 200 mg DHA from mid-pregnancy through lactation on the DHA concentrations in maternal and infant red blood cell phospholipids (RBC%), and in breast milk FA (%).

Methods: At 21 weeks' gestation, 144 women were enrolled into a randomised, double-blind clinical trial receiving daily: (1) a basic vitamin-mineral supplement (Vit/Min group), (2) Vit/Min plus 4.5 g fructo-oligosaccharide (FOS group), or (3) Vit/Min plus 4.5 g FOS plus 200 mg fish oil-derived DHA (DHA-FOS group). FAs were determined by capillary gas-liquid chromatography.

Results: While maternal RBC-DHA% at enrolment was not different, at 37 weeks gestation, and 3 months after delivery RBC-DHA% were significantly higher in the DHA-FOS group. The breast milk DHA% was twice as high in the DHA-FOS group (0.50%) than in the two others (0.25 %) (p < 0.001), and the ratio ARA/DHA in the DHA-FOS group was 1.0 +/- 0.43, in the others 2.1 +/- 0.43 (p < 0.001). The RBC-DHA% of the infants in the DHA-FOS group was also significantly higher, and correlated significantly with maternal RBC-DHA% before and 3 months after delivery.

Conclusions: In central Europe, a dose of 200 mg/day DHA from mid-pregnancy through lactation seems appropriate to improve the DHA status of mothers and infants.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study design.
Fig. 2
Fig. 2
RBC-DHA (wt%) of mothers and infants and DHA content in breast milk lipids (wt%) at 3 months after delivery. r = Pearson correlation coefficient.
Fig. 2
Fig. 2
RBC-DHA (wt%) of mothers and infants and DHA content in breast milk lipids (wt%) at 3 months after delivery. r = Pearson correlation coefficient.
Fig. 2
Fig. 2
RBC-DHA (wt%) of mothers and infants and DHA content in breast milk lipids (wt%) at 3 months after delivery. r = Pearson correlation coefficient.

Similar articles

Cited by

References

    1. IOM (Institute of Medicine) National Academy of Sciences: Nutrition during Pregnancy. Washington: National Academy Press; 1990.
    1. Picciano MF. Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr. 2003;133:1997S–2002S. - PubMed
    1. Allen LH. Multiple micronutrients in pregnancy and lactation: an overview. Am J Clin Nutr. 2005;81:1206S–1213S. - PubMed
    1. Glenville M. Nutritional supplements in pregnancy: commercial push or evidence based? Curr Opin Obstet Gynecol. 2006;18:642–647. - PubMed
    1. Roberfroid MB. Concepts and strategy of functional food science: The European perspective. Am J Clin Nutr. 2000;71:1660S–1664S. - PubMed

Publication types

MeSH terms